Technology Development at the ATP
The Advanced Technology Program’s (ATP) technology development effort aims to develop innovative technologies to ensure cutting edge core services that meet the current and future needs of the National Cancer Institute. These efforts parallel the three major areas of focus within the ATP: Genetics and Genomics, Proteins and Proteomics, and Imaging and Nanotechnology.
The technology development activities operate within a matrix of scientific and administrative oversight. For more information see: Technology Development Vision, Management Process, and Access to Technology Development Process.
The success of the ATP’s technology development activities are evident through the numerous augmentations to capabilities that have occurred over the years. The list of the on going technology development projects at the ATP are below:
(Use the clickable area below to narrow results)
23 Results
(Showing 1 - 10)
Absolute Quantitation of Biologically Important Proteins
http://ncifrederick.cancer.gov/atp/proteins-and-proteomics/laboratory-of-proteomics-and-analytical-technologies/technology-development/absolute-quantitation-of-biologically-important-proteins-in-clinical-samples/
Affinity Reagents for Analysis of the Human Cancer Proteome
http://ncifrederick.cancer.gov/atp/proteins-and-proteomics/protein-expression-laboratory/pel-technology-development/human-cancer-proteome/
Beyond Confocal
http://ncifrederick.cancer.gov/atp/cms/wp-content/uploads/2010/08/OMAL_Beyond_confocal_web_version.pdf
Characterization of Highly Specific Protein Complexes
http://ncifrederick.cancer.gov/atp/proteins-and-proteomics/laboratory-of-proteomics-and-analytical-technologies/technology-development/characterization-of-highly-specific-proteins-complexes/
Cryo-Electron Microscopy
http://ncifrederick.cancer.gov/atp/imaging-and-nanotechnology/electron-microscopy-laboratory/eml-services/cryo-electron-microscopy/
Detection of Weak or Transient Protein Interactions
http://ncifrederick.cancer.gov/atp/proteins-and-proteomics/protein-expression-laboratory/pel-technology-development/tap-and-mass-spec-protein-interaction/
Development of a Multiplex Onco-panel
http://ncifrederick.cancer.gov/atp/proteins-and-proteomics/protein-expression-laboratory/pel-technology-development/multiplexing-serological-testing-of-oncogenic-pathogens-to-support-hivcancer-epidemiology/
Dynamic Measurement of Proteins in Multiple Complexes
http://ncifrederick.cancer.gov/atp/proteins-and-proteomics/laboratory-of-proteomics-and-analytical-technologies/technology-development/dynamic-measurement-of-proteins-in-multiple-complexes/
Electron Tomography
http://ncifrederick.cancer.gov/atp/imaging-and-nanotechnology/electron-microscopy-laboratory/eml-technology-development/electron-tomography/
Enhanced Mammalian Protein Expression
http://ncifrederick.cancer.gov/atp/proteins-and-proteomics/protein-expression-laboratory/pel-technology-development/enhanced-protein-expression-in-mammalian-cells/
If you wish to hear more about the technology development efforts of the ATP, request the initiation of a new technology development effort, or inquire about an ongoing technology development project please contact Dr. David J. Munroe, Director, Technology Development, ATP.




